XML 105 R74.htm IDEA: XBRL DOCUMENT v3.21.2
Other Consolidated Financial Statement Detail (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Other Income (Expense), Net          
Interest income $ 2.6 $ 6.0 $ 8.2 $ 38.0  
Interest expense (66.3) (56.3) (187.3) (166.5)  
Gain (loss) on investments, net (424.5) (82.1) (707.2) (52.6)  
Foreign exchange gains (losses), net (13.7) 3.1 (23.1) (5.4)  
Other, net (1.0) 0.7 (4.0) 0.4  
Total other income (expense), net (502.9) (128.6) (913.4) (186.1)  
Equity Securities, FV-NI, Gain (Loss), Alternative [Abstract]          
Net gains (losses) recognized during the period on equity securities (424.2) (82.3) (705.9) (40.3)  
Less: Net gains (losses) realized during the period on equity securities 2.7 0.0 9.3 0.0  
Unrealized gains (losses) recognized during the period on equity securities (426.9) $ (82.3) (715.2) $ (40.3)  
Accrued Expenses and Other          
Revenue-related reserves for discounts and allowances 1,128.6   1,128.6   $ 1,276.0
Collaboration expense 299.2   299.2   333.8
Royalties and licensing fees 238.9   238.9   218.5
Collaboration expense 289.3   289.3   389.9
Current portion of contingent consideration obligations 0.0   0.0   149.6
Derivative liabilities 27.7   27.7   181.5
Other 713.2   713.2   791.4
Total accrued expense and other 2,550.7   2,550.7   3,145.3
Ionis, Sangamo, Denali and Sage          
Equity Securities, FV-NI, Gain (Loss), Alternative [Abstract]          
Unrealized gains (losses) recognized during the period on equity securities 424.3        
Component of accrued expenses and other          
Accrued Expenses and Other          
Revenue-related reserves for discounts and allowances $ 982.4   $ 982.4   $ 1,080.6